Masaru Kanekiyo
@kanekiyom.bsky.social
All views/posts are my own; vaccines for life; proteins are beautiful; vaccine design; viral immunity; host-vaccine interface; vaccine immunologist; cat dad
ORCiD: 0000-0001-5767-1532
ORCiD: 0000-0001-5767-1532
These antibodies target distinct epitopes somewhat conserved among H5 on HA globular head and are more potent than HA stem antibodies. The study was led by VRC in collaboration with @jbloomlab.bsky.social at Fred Hutch and Reed lab at UPitt. Huge thanks to all who contributed to the work! 2/2
October 14, 2025 at 3:10 PM
These antibodies target distinct epitopes somewhat conserved among H5 on HA globular head and are more potent than HA stem antibodies. The study was led by VRC in collaboration with @jbloomlab.bsky.social at Fred Hutch and Reed lab at UPitt. Huge thanks to all who contributed to the work! 2/2
That’s brilliant. Congrats Jason! Richly deserved.
October 9, 2025 at 12:59 PM
That’s brilliant. Congrats Jason! Richly deserved.
Nice pictures of you two. Not to scale tho.
May 7, 2025 at 11:15 PM
Nice pictures of you two. Not to scale tho.
Here’s a link for NIAID media release covering our paper. go.nih.gov/2Lb9nnn
New Antibodies Target “Dark Side” of Influenza Virus Protein
Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of the neura...
go.nih.gov
March 1, 2024 at 7:06 PM
Here’s a link for NIAID media release covering our paper. go.nih.gov/2Lb9nnn